US Oncology - Texas Oncology, PA - Fort Worth

Fort Worth, Texas 76104

We've found

1 trials

at this facility

First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Fort Worth, TX

Use our guide to learn which trials are right for you!